Reactive gastropathy is a pattern of stomach lining damage caused not by infection or autoimmune attack, but by chemical irritation. It shows up on about one in six gastric biopsies in the United States, making it more common than Helicobacter pylori infection in many clinical settings.1PubMed. Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract The usual culprits are painkillers, bile washing backward into the stomach, alcohol, and certain supplements. What makes the condition distinctive, and sometimes confusing, is that it causes visible tissue changes with surprisingly little inflammation.
What Causes Reactive Gastropathy
The list of triggers is shorter than you might expect, but each one damages the stomach lining through a slightly different route. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and aspirin are the single most common cause. These drugs suppress the production of prostaglandins, which are molecules the stomach relies on to maintain its protective mucus barrier, regulate acid output, and keep blood flowing to the lining. When prostaglandin levels drop, the stomach becomes vulnerable to its own acid.2PubMed. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage Beyond that chemical pathway, NSAIDs also rev up stomach contractions, which increases the permeability of the lining and sets off a cascade of tissue-level damage before an ulcer ever forms.3PubMed Central. Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility
Bile reflux is the second major trigger. Normally, bile flows from the gallbladder into the upper small intestine and stays there. But in people who have had stomach or gallbladder surgery, or sometimes for no clearly identified reason, bile can wash back through the pylorus into the stomach. Because bile acids are detergent-like molecules designed to break down fats, they also strip away the stomach’s mucus layer and injure the surface cells. In one study of patients with bile reflux gastropathy, those who had previously undergone gallbladder removal were far more likely to have the condition than those with an intact gallbladder.4PubMed Central. Bile Reflux Gastropathy and Functional Dyspepsia
Alcohol is another well-recognized irritant, damaging the gastric lining through direct contact. And then there are medications you might not suspect at all, particularly oral iron supplements, which deserve a closer look.
Iron Supplements as an Overlooked Trigger
Iron tablets are prescribed constantly for anemia, and most people tolerate them without serious trouble. But in some patients, especially older adults, ferrous sulfate tablets can cause a localized chemical burn to the stomach lining. The iron deposits a dark crystalline residue that erodes the mucosa in a concentration-dependent way, meaning the longer a tablet sits in one spot, the worse the injury.5PubMed Central. Iron Pill–Induced Gastritis On endoscopy, this can appear as scattered erosions, frank ulcers, or diffuse irritation. On biopsy, pathologists sometimes notice a brownish iron staining in the tissue, a finding called gastric siderosis that can be accompanied by nausea, indigestion, and even dark stools from mucosal bleeding.6PubMed Central. Gastric Siderosis Due to Oral Ferrous Sulfate Supplements
The irony is hard to miss: iron is prescribed to correct anemia, but if it causes enough stomach erosion, it can produce bleeding that worsens the anemia it was meant to fix. Iron pill gastropathy tends to be underrecognized, and switching to a liquid form of iron or intravenous iron can resolve the stomach damage in patients who need to continue treatment.7Scholarly Commons. Iron Pill-Induced Gastropathy in Elderly Patients: A Case Series Report
What Pathologists See on Biopsy
The diagnosis of reactive gastropathy ultimately rests on what a pathologist finds under the microscope. The hallmark features are a specific set of tissue changes that tend to occur together, though they can also appear individually or in varying combinations. These include overgrowth of the foveolar cells (the mucus-producing surface pits of the stomach), wisps of smooth muscle fibers extending up between those pits, swelling in the underlying tissue, dilated blood vessels, and surface erosions.8PubMed. Differential diagnosis of reactive gastropathy
What is conspicuously absent is significant inflammation. In conditions driven by infection, such as H. pylori gastritis, the biopsy is packed with immune cells. In reactive gastropathy, the immune cell population is minimal or absent entirely. This is one of the most important clues for the pathologist: the tissue looks injured, but the body’s inflammatory response is muted. A pediatric study confirmed this same constellation of features in children, finding foveolar hyperplasia, congestion, tissue swelling, smooth muscle fibers, and a near-absence of inflammation in the vast majority of affected biopsies.9Journal of Pediatric Gastroenterology and Nutrition. Chemical Gastropathy: A Distinct Histopathologic Entity in Children
This lack of inflammation is precisely why the condition is called a “gastropathy” rather than a “gastritis.” In medical terminology, the suffix “-itis” implies inflammation, and true gastritis has it in abundance. Gastropathy, by contrast, describes structural damage without a significant inflammatory infiltrate. The distinction matters clinically because treatments aimed at suppressing inflammation (like antibiotics for H. pylori) will not help, and the approach instead focuses on removing or neutralizing whatever chemical agent is doing the harm.
How It Looks During Endoscopy
During an upper endoscopy, reactive gastropathy often has a recognizable visual pattern, though it is not always dramatic. One of the more characteristic findings is reddish streaks running along the folds of the stomach lining, particularly in the antrum (the lower portion of the stomach nearest the pylorus). A study of these streaks found that they correlated with the histological features of reactive gastropathy, occurred in stomachs with low rates of H. pylori infection, and were likely related to bile reflux.10PubMed. Gastric reddish streaks in the intact stomach: endoscopic feature of reactive gastropathy Other endoscopic appearances can include mucosal redness, swollen folds, scattered erosions, or a bile-stained pool of fluid in the stomach. None of these findings alone is specific enough to make the diagnosis. The endoscopist sees something suspicious, takes biopsies, and the pathologist confirms it.
The clinical challenge is that many people with reactive gastropathy have vague symptoms, or none at all. When symptoms do appear, they tend to overlap with garden-variety indigestion: a gnawing or burning pain in the upper abdomen, nausea, and occasionally a sensation of bloating. Some patients report that their symptoms do not respond to standard acid-blocking medications, which makes sense when bile rather than acid is the primary irritant.
How Common It Is and Who Gets It
Reactive gastropathy is not rare. A large analysis of gastric biopsies across the United States found it in about 15.6% of patients, slightly exceeding the 10.3% rate of H. pylori infection.11PubMed. Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract The condition was spread evenly across geographic regions and increased steadily with age, rising from around 2% in the first decade of life to over 20% in people in their eighties. That age gradient makes intuitive sense: older adults are far more likely to be taking daily NSAIDs or aspirin for pain or cardiovascular protection, and they are more likely to have had prior abdominal surgeries that predispose to bile reflux.
Post-surgical patients deserve special mention. After operations that alter the stomach’s plumbing, bile reflux becomes common. In patients who had undergone Roux-en-Y gastric bypass, biopsies of the remnant stomach showed reactive gastropathy in about 90% of cases, and imaging confirmed bile reflux across the pylorus in every patient tested.12PubMed. Bile reflux of the remnant stomach following Roux-en-Y gastric bypass: an etiology of chronic abdominal pain treated with remnant gastrectomy For these patients, chronic abdominal pain after surgery may not be a mystery at all; it is bile corroding a stomach segment that was never meant to sit in a bath of detergent-like fluid.
Does Reactive Gastropathy Raise Cancer Risk?
This is the question many patients ask once they see “gastropathy” on a pathology report, and the answer is more reassuring than they might expect. A large observational study in Denmark tracked patients with various gastric precancerous conditions over time. Among the different biopsy diagnoses, reactive gastropathy was the one group that did not show an increased incidence of gastric cancer.13PubMed Central. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population This sets it apart from intestinal metaplasia, atrophic gastritis, and dysplasia, all of which carried elevated risk in the same study.
That said, the picture is not entirely clean. A separate study found that patients with reactive gastropathy in the antrum had higher rates of intestinal metaplasia around the junction where the esophagus meets the stomach. Intestinal metaplasia at that junction is considered a precursor to a particular type of cancer there. The researchers attributed this link to the ongoing bile reflux that caused the reactive gastropathy in the first place, suggesting that bile reflux may promote tissue changes further upstream even if the gastropathy itself is not the direct cancer precursor.14PubMed Central. Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction The practical takeaway is that reactive gastropathy alone does not place you on a cancer surveillance track, but if bile reflux is the underlying driver, addressing it early may help prevent more advanced mucosal changes elsewhere in the upper digestive tract.
Treatment When NSAIDs Are the Problem
The simplest fix, when feasible, is to stop the offending drug. If you are taking ibuprofen daily for chronic joint pain and your biopsy shows reactive changes, your doctor will likely explore alternatives. But for many patients, particularly those on low-dose aspirin for heart disease or on NSAIDs for conditions like rheumatoid arthritis, stopping is not realistic.
Proton pump inhibitors (PPIs) are the standard co-therapy in this scenario. They work by drastically reducing stomach acid production, which removes one of the damaging factors even though acid is not the sole cause of the problem. PPIs have been shown in randomized trials to heal NSAID-associated ulcers, including in patients who continue taking the NSAID, and to reduce the risk of new ulcers forming while NSAID use continues.15PubMed Central. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage
Misoprostol, a synthetic prostaglandin, takes a different approach. Because NSAIDs cause damage partly by depleting the stomach’s natural prostaglandins, replacing them with an external supply can protect the lining. Studies have shown that misoprostol reduces small-intestinal mucosal damage from NSAIDs and can even heal ulcers caused by low-dose aspirin.16Gut and Liver. Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract The downside is that misoprostol commonly causes diarrhea and cramping, which limits its tolerability at higher doses.
Rebamipide, a mucosal protectant widely available in parts of Asia, has also shown promise. In high-risk patients taking NSAIDs for 12 weeks, rebamipide appeared to prevent gastric ulcers at a rate comparable to PPIs.17PubMed Central. Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity It is not as widely prescribed in Western countries, but it represents an option for patients who cannot tolerate PPIs or misoprostol.
Treating Bile Reflux Gastropathy
When bile reflux is the culprit, the management strategy shifts substantially. Acid-blocking medications are less effective here because the problem is not excess acid but rather caustic bile components washing into a place they do not belong. Ursodeoxycholic acid (UDCA), a naturally occurring bile acid that is less toxic to cell membranes than the dominant bile acids, has been used to change the composition of the refluxed bile. An early randomized trial found that one month of UDCA treatment dramatically reduced pain intensity and nearly eliminated the nausea and vomiting associated with bile reflux gastritis.18PubMed. Ursodeoxycholic acid treatment of bile reflux gastritis
More recent pooled data support that finding. A systematic review and meta-analysis found that adding UDCA to standard treatment significantly reduced the number of reflux episodes, shortened the longest reflux durations, and improved overall symptom scores compared to standard therapy alone.19PubMed Central. Clinical Efficacy of Ursodeoxycholic Acid in Bile Reflux Gastritis: A Systematic Review and Meta-Analysis UDCA is generally well tolerated and does not carry the long-term concerns sometimes associated with indefinite PPI use, making it attractive for a condition that may require ongoing management.
For patients with severe bile reflux that does not respond to medication, especially those whose anatomy has been altered by prior surgery, a surgical diversion procedure may be considered. One approach reroutes the intestinal contents so that bile no longer reaches the stomach. A study evaluating surgical outcomes reported that the vast majority of patients experienced significant pain relief and elimination of vomiting in the short term, and about half rated their long-term results as excellent.20PubMed. Alkaline reflux gastritis: early and late results of surgery Endoscopic findings improved after six months, though the microscopic tissue changes in biopsies were slower to resolve. Surgery remains a last resort, but it exists as an option when medical therapy falls short.
How Bile Reflux Changes the Stomach’s Microbial Landscape
An emerging area of research is how bile reflux reshapes the community of bacteria living on the stomach’s surface. The stomach has long been thought of as nearly sterile (aside from H. pylori), but sequencing studies have shown that a diverse microbial community exists there. When bile reflux occurs, that community shifts. A study comparing the gastric microbiota of patients with and without bile reflux found that reflux patients harbored a distinct set of bacterial genera, including Pseudomonas and Comamonas, while genera like Haemophilus and Porphyromonas were more common in people without reflux.21PubMed Central. Bile reflux alters the profile of the gastric mucosa microbiota
What these shifts mean for the patient is still being worked out. Bile acids are known to be antimicrobial, so it makes sense that flooding the stomach with bile would selectively favor bacteria that can tolerate that harsh environment. Whether the altered microbiome contributes to symptoms, drives further mucosal injury, or is simply a bystander effect of the chemical environment remains unclear. But the finding adds a layer of complexity to bile reflux gastropathy that was invisible before sequencing technology made it possible to catalog these communities.
When the Pathology Report Creates Confusion
One of the most common points of confusion arises when patients receive a biopsy result reading “reactive gastropathy” without much context. Because the condition can be found incidentally during an endoscopy performed for other reasons, people sometimes assume the finding implies a serious diagnosis. In practice, identifying the trigger matters more than the biopsy label. If you are taking a daily NSAID and your biopsy shows reactive changes, the finding is essentially confirming what was already expected. It becomes clinically meaningful mainly when the cause is not obvious, when symptoms are persistent, or when the pathologist notes features that might suggest a more concerning condition masquerading as simple chemical injury.22PubMed. Differential diagnosis of reactive gastropathy
Pathologists sometimes flag that the biopsy findings should prompt a conversation between the patient and the treating physician about whether certain medications could be reduced, switched, or stopped. Although the direct link between reactive gastropathy on biopsy and a patient’s specific risk of bleeding has not been firmly quantified, the suspicion of drug-induced damage can be enough to prompt a medication review that benefits the patient overall. For bile-related cases, the biopsy finding may be the first concrete evidence that reflux is occurring, pointing toward diagnostic workup and treatment that would not have been considered otherwise.